Goldman Sachs Group Inc Pfizer Inc Transaction History

Goldman Sachs Group Inc

$605 Billion
Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Pfizer Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 25,826,618 shares of PFE stock, worth $644 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares

25,826,618

Previous 34,916,739 26.03%

Holding current value

$644 Million

Previous $977 Million 23.5%

% of portfolio

0.12%

Previous 0.17%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $252 Million - $285 Million	-9,090,121 Reduced 26.03%	25,826,618 $747 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $318 Million - $372 Million	12,569,585 Added 56.25%	34,916,739 $977 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $44.6 Million - $51.2 Million	-1,722,272 Reduced 7.16%	22,347,154 $620 Million
Q4 2023 Feb 13, 2024	SELL	$26.13 - $33.94 $13.4 Million - $17.4 Million	-511,767 Reduced 2.08%	24,069,426 $693 Million
Q3 2023 May 14, 2024	BUY	$32.09 - $37.51 $16.4 Million - $19.2 Million	511,767 Added 2.13%	24,581,193 $815 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $52.2 Million - $61.1 Million	-1,627,801 Reduced 6.21%	24,581,193 $815 Million
Q2 2023 May 14, 2024	BUY	$36.12 - $41.79 $86.6 Million - $100 Million	2,397,511 Added 10.07%	26,208,994 $961 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $86.6 Million - $100 Million	2,397,511 Added 10.07%	26,208,994 $961 Million
Q1 2023 May 14, 2024	SELL	$39.39 - $51.28 $46.2 Million - $60.1 Million	-1,172,040 Reduced 4.69%	23,811,483 $972 Million
Q1 2023 May 11, 2023	SELL	$39.39 - $51.28 $46.2 Million - $60.1 Million	-1,172,040 Reduced 4.69%	23,811,483 $972 Million
Q4 2022 May 14, 2024	BUY	$41.75 - $54.5 $128 Million - $166 Million	3,053,993 Added 13.93%	24,983,523 $1.28 Billion
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $128 Million - $166 Million	3,053,993 Added 13.93%	24,983,523 $1.28 Billion
Q3 2022 May 14, 2024	BUY	$43.76 - $53.42 $2.79 Million - $3.4 Million	63,669 Added 0.29%	21,929,530 $960 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $2.79 Million - $3.4 Million	63,669 Added 0.29%	21,929,530 $960 Million
Q2 2022 May 14, 2024	SELL	$46.53 - $55.17 $103 Million - $122 Million	-2,203,565 Reduced 9.16%	21,865,861 $1.15 Billion
Q2 2022 Aug 15, 2022	BUY	$46.53 - $55.17 $94.6 Million - $112 Million	2,033,150 Added 10.25%	21,865,861 $1.15 Billion
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $95.6 Million - $119 Million	2,090,429 Added 11.78%	19,832,711 $1.03 Billion
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $36.8 Million - $54.6 Million	-890,845 Reduced 4.78%	17,742,282 $1.05 Billion
Q3 2021 Nov 10, 2021	BUY	$39.25 - $50.42 $731 Million - $939 Million	18,633,127 New	18,633,127 $801 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $140B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Account

Goldman Sachs Group Inc Pfizer Inc Transaction History